CLX-0301

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCLX-0301

Drug Alias NameCLX-0301

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein kinases inhibitors

TargetsProtein kinases

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTheracos Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTheracos Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus

ATC CodeN/A